Report Information More information from: https://www.wiseguyreports.com/reports/1474115
EpiCast Report: Venous Thromboembolism - Epidemiology Forecast to 2026 Report / Search Code: WGR1474115
Price
Publish Date: 1 June, 2017
1-user PDF : $ 3995.0
Site PDF : $ 7990.0
Enterprise PDF : $ 11985.0
Description:
EpiCast Report: Venous Thromboembolism - Epidemiology Forecast to 2026 Summary Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in affected individuals. VTE can occur at any age, but it is more common in adults ages 60 years and older and is very rare in children. VTE events are highly dangerous and are associated with high rates of mortality and morbidity. GlobalData epidemiologists forecast an increase in the diagnosed incident cases of VTE in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan), from 896,377 cases in 2016 to 1,071,438 in 2026, at an Annual Growth Rate (AGR) of 1.95%.The number of VTE attacks is forecast to grow from 1,020,991 in 2016 to 1,224,696 in 2026 in the 7MM. GlobalData epidemiologists have identified the predominant drivers of this market to be changes in countryspecific incidence and procedure rates, as well as in the underlying demographic trends. GlobalData epidemiologists forecast the prevalent cases of VTE in the 7MM from 2016-2026 using nationally-representative, country-specific studies published in peer-reviewed journals that provided the age- and sex-specific incidence of VTE, DVT, and PE in the 7MM. Additionally, they forecast the number of VTE attacks, medically ill discharges at risk of VTE, knee and hip replacements, recurrent VTE cases at one and 10 years, and VTE cases with cancer as comorbidity. GlobalData epidemiologists ensured that the forecast methodology was consistent across all the 7MM to allow for a meaningful comparison of the diagnosed incident cases of VTE across these markets. Scope - The Venous Thromboembolism (VTE) EpiCast Report provides an overview of the risk factors and global trends of VTE in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiology forecast of diagnosed incident cases of VTE, deep vein thrombosis, and pulmonary embolism segmented by sex and age (in five-year increments beginning at ages zero to four years and ending at 85 years and older) in these seven markets. Additionally, this report includes the number of VTE attacks, medically ill discharges at risk of VTE, primary total knee and hip replacements, recurrent VTE cases after one and 10 years, and diagnosed VTE cases with cancer as comorbidity. - The VTE epidemiology report is written and developed by Masters- and PhD-level epidemiologists. - The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM. Reasons to buy The VTE EpiCast report will allow you to - Develop business strategies by understanding the trends shaping and driving the global VTE market. - Quantify patient populations in the global VTE market to improve product design, pricing, and launch plans. - Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for VTE therapeutics in each of the markets covered. - Identify the percentage of VTE cases with recurrence of VTE and percentage of VTE cases with cancer as comorbidity
Contents:
1 Table of Contents 1 Table of Contents 2
1.1 List of Tables 3 1.2 List of Figures 3 2 Venous Thromboembolism: Executive Summary 4 2.1 Related Reports 6 2.2 Upcoming Related Reports 6 3 Introduction 7 3.1 Disease Background 7 3.2 Risk Factors and Comorbidities 8 3.3 Global and Historical Trends 9 3.4 Forecast Methodology 11 3.4.1 Sources 11 3.4.2 Forecast Assumptions and Methods 13 3.5 Epidemiological Forecast for VTE (2016-2026) 24 3.5.1 Diagnosed Incident Cases of Pulmonary Embolism 24 3.5.2 Diagnosed Incident Cases of Deep Vein Thrombosis 25 3.5.3 Diagnosed Incident Cases of VTE 26 3.5.4 Age-Specific Diagnosed Incident Cases of VTE 28 3.5.5 Sex-Specific Diagnosed Incident Cases of VTE 29 3.5.6 One- and 10-Year First Time Recurrent Cases of VTE 29 3.5.7 Number of VTE Cases with Cancer as Comorbidity 30 3.5.8 Number of VTE Attacks 31 3.5.9 Number of Hospital Discharges Meeting Criteria for Medically Ill and Those at Risk for VTE 31 3.5.10 Number of Primary Total Knee Replacements and Revisions 32 3.5.11 Number of Hip Replacements 33 3.6 Discussion 34 3.6.1 Epidemiological Forecast Insight 34 3.6.2 Limitations of the Analysis 35 3.6.3 Strengths of the Analysis 35 4 Appendix 36 4.1 Bibliography 36 4.2 Physicians and Specialists Included in this Study 38 4.3 Primary Research - Key Opinion Leaders Interviewed for this Report 40 4.4 About the Authors 43 4.4.1 Epidemiologist 43 4.4.2 Reviewers 43 4.4.3 Global Director of Therapy Analysis and Epidemiology 44 4.4.4 Global Head and EVP of Healthcare Operations and Strategy 44 4.5 About GlobalData 44 4.6 Contact Us 45 4.7 Disclaimer 45 1.1 List of Tables Table 1: Risk Factors and Comorbidities for Venous Thromboembolism 8 Table 2: 7MM, Diagnosed Incident Cases of PE, Men and Women, All Ages, N, Select Years, 2016-2026 25 Table 3: 7MM, Diagnosed Incident Cases of DVT, Men and Women, All Ages, N, Select Years, 2016-2026 26 Table 4: 7MM, Diagnosed Incident Cases of VTE, Men and Women, All Ages, N, Select Years, 2016-2026 27 Table 5: 7MM, One- and 10-Year Recurrent VTE Cases, Men and Women, All Ages, N, 2016 30 Table 6: Number of VTE Cases With Cancer Comorbidity, Men and Women, All Ages, N, 2016 and 2026 30 Table 7: 7MM, Number of VTE Attacks, Men and Women, All Ages, N, Select Years, 2016-2026 31 Table 8: 7MM, Number of Hospital Discharges Meeting Criteria for Medically Ill; Those at risk for VTE, Men and Women, Ages ≥40 Years, N, 2016 32 Table 9: 7MM, Number of Primary Total Knee Replacements and Revisions, Men and Women, Ages ≥15 Years, N, Select Years, 2016-2026 33 Table 10: 7MM, Number of Hip Replacements, Men and Women, Ages ≥15 Years, N, Select Years, 2016-2026 34 1.2 List of Figures Figure 1: 7MM, Diagnosed Incident Cases of VTE, Men and Women, All Ages, 2016 and 2026 5 Figure 2: 7MM, Number of VTE Attacks, Men and Women, All Ages, 2016 and 2026 5 Figure 3: 7MM, Age-Standardized Diagnosed Incidence of PE, All Ages, Cases per 100,000 Population, 2016 10 Figure 4: 7MM, Age-Standardized Diagnosed Incidence of DVT, All Ages, Cases per 100,000, 2016 11 Figure 5: 7MM, Sources Used to Forecast Diagnosed Incident Cases of PE and DVT, 2016 12 Figure 6: 7MM, Sources Used to Forecast the Number of Hospital Discharges that Meet the Criteria
for Medically Ill. 2016 12 Figure 7: 7MM, Sources Used to Forecast Primary Total Knee Replacements and Hip Replacements. 2016 13 Figure 8: 7MM, Age-Specific Diagnosed Incident Cases of VTE, Men and Women, N 28 Figure 9: 7MM, Sex-Specific Diagnosed Incident Cases of VTE, All Ages, N, 2016 29
wiseguyreports.com / Phone (US) + 1-646-845-9349 (UK) +44 208 133 9349